Fig. 1From: A two years open-label prospective study of OnabotulinumtoxinA 195 U in medication overuse headache: a real-world experienceComparison of the mean change in frequency of headache days in the OnabotulinumtoxinA 155 U and 195 U treated groups. *p < 0.001Back to article page